David M. Polen
Polen Capital Management
Polen Capital Management Eton Pharmaceuticals Inc stake
total: 588
Polen Capital Management ETON trades
- Total transactions:
- 2
- New positions:
- 1
- Added:
- 1
- Held since:
- 2026 Q1
- Held for:
- 2 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Polen Capital Management holds 45,379 Eton Pharmaceuticals Inc (ETON) shares with a market value of roughly $1.64M accounting for 0.01% of the overall portfolio. To date, the estimated cost basis is nearly $28.55 for "buy" trades. Polen Capital Management first purchased ETON in 2026 Q1, initially acquiring 30,138 shares. Since the initial investment in Eton Pharmaceuticals Inc (ETON), Polen Capital Management has made 1 more transaction.
When did Polen Capital Management buy Eton Pharmaceuticals Inc (ETON)?
Polen Capital Management first invested in Eton Pharmaceuticals Inc (ETON) in 2026 Q1 at the reported quarter-end price of $24.68 per share.
What's the cost basis of Polen Capital Management's ETON stake?
The estimated cost basis for Eton Pharmaceuticals Inc (ETON) stake is around $28.55 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $28.55
Polen Capital Management's historical trades in Eton Pharmaceuticals Inc
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.01%
|
45,379
|
$36.20
|
$1,642,720
|
+50.57% (+15,241)
|
+0%
|
|
2026 Q1
|
0.01%
|
30,138
|
$24.68
|
$743,806
|
new
|
+0.01%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.